Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q2 2023 Earnings Call Transcript August 8, 2023
Operator: Welcome to Acorda Therapeutics Second Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request. I will now introduce your host for today’s call, Tierney Saccavino with Acorda. Tierney, please go ahead.
Tierney Saccavino:...
